
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England
Emma Copland, Martina Patone, Defne Saatci, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Emma Copland, Martina Patone, Defne Saatci, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Long-Term Response to SARS-CoV-2 mRNA Vaccine in Adolescents
Mi Seon Han, Su-Jin Choi, Yoonsun Yoon, et al.
The Pediatric Infectious Disease Journal (2025)
Closed Access
Mi Seon Han, Su-Jin Choi, Yoonsun Yoon, et al.
The Pediatric Infectious Disease Journal (2025)
Closed Access
Myocarditis Associated with COVID-19 Vaccination
Kamila Florek, Mateusz Sokolski
Vaccines (2024) Vol. 12, Iss. 10, pp. 1193-1193
Open Access | Times Cited: 1
Kamila Florek, Mateusz Sokolski
Vaccines (2024) Vol. 12, Iss. 10, pp. 1193-1193
Open Access | Times Cited: 1
Selecting the most informative positive and negative controls for self-controlled case series (SCCS): Rationale, approach, and lessons from studies investigating the safety of COVID-19 vaccines
Igor Rudan, Srinivasa Vittal Katikireddi, Steven Kerr, et al.
Journal of Global Health (2024) Vol. 14
Open Access
Igor Rudan, Srinivasa Vittal Katikireddi, Steven Kerr, et al.
Journal of Global Health (2024) Vol. 14
Open Access
Identifying and reducing risks of neurological complications associated with vaccination
Lahiru Handunnetthi, Maheshi Ramasamy, Lance Turtle, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 9, pp. 541-554
Closed Access
Lahiru Handunnetthi, Maheshi Ramasamy, Lance Turtle, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 9, pp. 541-554
Closed Access
The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria–Tetanus–Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring the Roles of Heterologous Immunity
Theresia Santi, Juandy Jo, Alida Harahap, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1032-1032
Open Access
Theresia Santi, Juandy Jo, Alida Harahap, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1032-1032
Open Access
The global, regional, and national burden of myocarditis in 204 countries and territories, 1990–2021: Results from the Global Burden of Disease Study 2021
Le Li, Ligang Ding, Lingmin Wu, et al.
European Journal of Heart Failure (2024)
Closed Access
Le Li, Ligang Ding, Lingmin Wu, et al.
European Journal of Heart Failure (2024)
Closed Access
Parental decisions regarding the vaccination of children and adolescents against SARS-CoV-2 from 2020 to 2023: A descriptive longitudinal study of parents and children in Montreal, Canada
Katia Charland, Caroline Quach, Jesse Papenburg, et al.
Vaccine (2024) Vol. 43, pp. 126489-126489
Open Access
Katia Charland, Caroline Quach, Jesse Papenburg, et al.
Vaccine (2024) Vol. 43, pp. 126489-126489
Open Access
EARLY ADVERSE EFFECTS AFTER COVID-19 VACCINE IN CHILDREN AND ADOLESCENTS WITH PSYCHIATRIC DISORDERS
Seda Kafalı, Selma Tural Hesapçıoğlu, Dilan Aydin, et al.
Türk tıp dergisi. (2024)
Open Access
Seda Kafalı, Selma Tural Hesapçıoğlu, Dilan Aydin, et al.
Türk tıp dergisi. (2024)
Open Access
Adverse reactions to mRNA COVID-19 vaccine in people with allergies in Japan
Nahoko Shoji, Suminobu Ito, Shuko Nojiri, et al.
Global Health & Medicine (2024) Vol. 6, Iss. 6, pp. 363-374
Closed Access
Nahoko Shoji, Suminobu Ito, Shuko Nojiri, et al.
Global Health & Medicine (2024) Vol. 6, Iss. 6, pp. 363-374
Closed Access
Safety and durability of the immune response after vaccination with the heterologous schedule of anti-COVID-19 vaccines SOBERANA®02 and SOBERANA® Plus in children 3–18 years old
Dagmar García-Rivera, Rinaldo Puga-Gómez, Sonsire Fernández-Castillo, et al.
Vaccine X (2024) Vol. 22, pp. 100595-100595
Open Access
Dagmar García-Rivera, Rinaldo Puga-Gómez, Sonsire Fernández-Castillo, et al.
Vaccine X (2024) Vol. 22, pp. 100595-100595
Open Access